Filing Details

Accession Number:
0001128732-16-000018
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-26 08:49:58
Reporting Period:
2016-04-12
Filing Date:
2016-04-26
Accepted Time:
2016-04-26 08:49:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1402328 Sunshine Biopharma Inc SBFM Services-Commercial Physical & Biological Research (8731) 205566275
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1474684 N. Steve Slilaty 579 Rue Lajeunesse
Laval A8 H7X 3K4
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-04-12 253,082 $0.20 30,570,776 No 4 P Indirect Owned by Advanomics Corporation, an entity controlled by Reporting Person.
Common Stock Acquisiton 2016-04-22 12,000,000 $0.01 12,384,373 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Owned by Advanomics Corporation, an entity controlled by Reporting Person.
No 4 A Direct